In this study, we first reported FLOT1 as a potential molecular marker in the development of glioma, as evidence suggested that FLOT1 is closely associated with clinicopathological features and immune surveillance of gliomas and promoted glioma cell proliferation, invasion and migration. Here, FLOT1 is linked to central nervous system cancer.